StockHealthcare · Biotechnology

$BSEM

BIOSTEM TECHNOLOGIES

Price · $BSEMvia TradingView

AI sentiment · 7d0 articles

No enriched coverage for $BSEM in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $BSEM in the last 30 days.

BioStem Technologies to Present at the Centri Capital Conference

POMPANO BEACH, Fla., April 21, 2025 ( GLOBE NEWSWIRE ) -- BioStem Technologies, Inc. ( OTC: BSEM ) , a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, is pleased to announce that its Chief Executive ...

APR 14·Benzinga

BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million - BioStem Technologies ( OTC:BSEM )

Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or $0.94 per share, marking the fourth consecutive quarter of profitability

via TradingView

News on $BSEM

All news →